1Reaven GM. Role of insulin resistance in human disease[J].Diabetes,1988,37: 1595-1697.
2Clark A,Jones LC,DE Koming E, et al. Decreased insulin secretion in type 2 diabetes: a problem of cellular mass or function[J].Diabetes,2001,50(suppl 1): s169-s171.
3Unger RH,Zhou YJ. Lipotoxicity of beta-cells in obesity and in other cause of fatty acid spillover[J].Diabetes,2001,50(Suppl 1): s118-s121.
4Cnop M,Hannaert JC,Hoorens A,et al. Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation[J].Diabetes,2001,50(8):1771-1777.
5Haffiner S M, D'Agostino, Mykkanen L. Insulin sensitivity in subjects with type 2 diabetes[J].Diabetes Care, 1999,22(4): 562-568.
7Groop L G. Insulin resistance: the fundamental trigger of type 2 diabetes[J].Diabetes Obes Metab,1999,1(Suppl 1): s1-7.
8傅祖植. 糖尿病.叶任高. 内科学(第5版)[M]. 北京:人民卫生出版社,2000. 805.
9Bagdade JD, Dunn FL, Eckel RH, et al. Intraperitoneal insulin therapy corrects abnormalities in cholesterol ester transfer and lipoprotein lipase activities in insulin-dependent diabetes mellitus[J].Arterioscler Thromb,1994,14(12): 1933-1939.
10Agata J, miyazaki Y, Takada M, et al. Association of insulin resistance and hyperinsulinemia with disturbed lipid metabolism in patients ential hypertension[J].Hypertens Res,1998,21(1): 57-62.
